Samsung Biologics Co.,Ltd. (KRX:207940)
South Korea
· Delayed Price · Currency is KRW 1,085,000
+33,000 (3.14%)
At close: May 2, 2025, 3:30 PM KST
Samsung Biologics Market Cap
Samsung Biologics has a market cap or net worth of 77.22 trillion as of May 6, 2025. Its market cap has increased by 33.62% in one year.
Market Cap
77.22T
Enterprise Value
77.38T
Revenue
4.55T
Ranking
n/a
PE Ratio
71.28
Stock Price
1,085,000.00
Market Cap Chart
Since November 10, 2016, Samsung Biologics's market cap has increased from 9.53T to 77.22T, an increase of 710.51%. That is a compound annual growth rate of 27.99%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Celltrion | 34.62T |
| ALTEOGEN | 19.00T |
| Yuhan | 8,496.01B |
| SK Biopharmaceuticals | 8,410.84B |
| HLB Co., Ltd. | 7,528.95B |
| PharmaResearch | 4,046.77B |
| Peptron | 3,967.54B |
| LigaChem Biosciences | 3,925.71B |